Tueor Technologies Calls for Investment and Partnerships to Secure Vulnerable Medical Devices with Magloc

Magloc is not just an innovation - it is a call to action. The team at Tueor Technologies, led by CEO Dave Hopson, COO Dan Greene, and CSO Jim Hair, has not only secured a patent for this groundbreaking technology but also created a working prototype. Now, the company is actively seeking investors and partners in the medical manufacturing sector to bring this critical solution to market.

The importance of medical device cybersecurity cannot be overstated. As AI evolves, it is increasingly used to breach security systems. According to Dave, AI accelerates the rate at which hackers can infiltrate systems, making it nearly impossible to keep pace with traditional security measures. “AI makes all cybersecurity more difficult because viruses can mutate faster than you can create a software fix,” the CEO explains. “This is especially true for medical devices where the stakes are literally life and death.”

Medical devices have become prime targets for hackers due to their inherent vulnerabilities. Billy Rios, a cybersecurity expert, demonstrated this reality when he hacked a pacemaker at the Black Hat conference in 2018. His demonstration underscored that while some issues may have been addressed, many devices remain unprotected, and the risk of ransomware attacks on medical implants is growing.

Dave points out that even large companies are at risk. A hypothetical scenario where a hacker compromises pacemakers to demand billions in ransom is not far-fetched in today’s AI-driven world. “If the public knew just how vulnerable these devices are, there would be tremendous pressure on manufacturers to act,” he says.

Tueor’s hardware-based technology uses a wafer placed on the outside of the pacemaker. This wafer controls the device’s telemetry, preventing unauthorized communication unless activated by a special key fob that the patient must hold in a specific orientation. The technology offers a defensible barrier for medical devices, featuring a patented magnetic lock that only the patient and their medical provider control.

The real innovation behind Magloc is in its simplicity and effectiveness. It consumes minimal power - unlike other solutions that rely on software and are too power-hungry for medical devices - and it integrates seamlessly with existing medical implants without requiring any modifications. This is critical because it means Magloc can be rapidly adopted without disrupting the manufacturing process of existing devices.

“Other companies rely on software for protection, but that’s not feasible for implants. The software requires too much power and isn’t practical for devices like pacemakers,” explains Jim Hair, Tueor’s CSO. “Our solution is hardware-based and prevents ransomware attacks without the need for constant updates or excessive power consumption.”

The opportunity for investment is significant. The implantable device market is valued at $115 billion and continues to grow. Millions of medical devices are implanted annually in the U.S. alone, with 200,000 of those being pacemakers. With FDA pressure mounting for improved device security and no existing fix for the vulnerabilities that hackers like Billy Rios have exposed, Tueor is in a strong position to secure partnerships and funding. Their plan includes acquiring their first customer within the first year, generating $1.2-$2.6 million in revenue, and achieving positive cash flow shortly thereafter.

To support their expansion, Tueor is offering a $3 million convertible note to fund the next stages of development and miniaturization of their technology. Investors can expect to see significant returns as the company moves toward a five-year exit strategy. Magloc’s potential doesn’t stop at pacemakers; the same technology can be applied to insulin pumps, drug delivery systems, and even autonomous vehicles and drones.

What sets Tueor apart from competitors is the team’s unique expertise in both medical device manufacturing and cybersecurity. Jim Hair brings more than 30 years of experience, including hands-on experience developing pacemakers, while Dan Greene has worked extensively with the federal government on cybersecurity initiatives. Together, they possess a rare combination of skills that allow them to tackle both the medical and cybersecurity challenges that no other company can address as effectively.

Greene’s wife and daughter both have medical implants and Dave’s daughter also has a VNS implant, making the mission deeply personal. Dave, who holds a Ph.D. in econometrics, adds the business acumen needed to guide the company toward a successful exit.

As cybersecurity risks continue to escalate with the rise of AI, the need for Magloc has never been more urgent. Tueor Technologies is offering a rare opportunity for investors and manufacturers to join forces in securing a vulnerable, yet critical, market. By partnering with Tueor, medical device manufacturers have the chance to leapfrog competitors and become the first to offer ransomware-protected medical devices, a feature that could save countless lives.

For investors, the return is clear: a chance to secure a foothold in a $155 billion market while addressing a growing global security concern. With a patented solution, an experienced team, and a market ripe for disruption, Tueor Technologies stands ready to protect the future of medical implants - and the lives of those who depend on them.